Literature DB >> 2685528

Histiocytosis syndromes in children: II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis. Clinical Writing Group of the Histiocyte Society.

V Broadbent1, H Gadner, D M Komp, S Ladisch.   

Abstract

Langerhans cell histiocytosis (LCH) has presented problems in diagnosis and in treatment. The definitive diagnosis is a pathologic one. To advance thorough and uniform assessment of these patients, the elements of a complete clinical and laboratory evaluation are presented by the Histiocyte Society. Adoption of a uniform clinical/laboratory approach to these children, coupled with agreed-upon steps to the pathologic identification of LCH, should result in a better understanding and ultimately better and more rational therapies for the disease.

Entities:  

Mesh:

Year:  1989        PMID: 2685528     DOI: 10.1002/mpo.2950170527

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  27 in total

1.  Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis.

Authors:  P H Hoeger; V R Nanduri; J I Harper; D A Atherton; J Pritchard
Journal:  Arch Dis Child       Date:  2000-06       Impact factor: 3.791

2.  Bone marrow findings at diagnosis in patients with multisystem langerhans cell histiocytosis.

Authors:  Maria Laura Galluzzo; Jorge Braier; Sergio D Rosenzweig; Maria T Garcia de Dávila; Diego Rosso
Journal:  Pediatr Dev Pathol       Date:  2010 Mar-Apr

Review 3.  Langerhans cell histiocytosis (histiocytosis X).

Authors:  K Y Lam
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

4.  Differentiating skin-limited and multisystem Langerhans cell histiocytosis.

Authors:  Stephen J Simko; Benjamin Garmezy; Harshal Abhyankar; Philip J Lupo; Rikhia Chakraborty; Karen Phaik Har Lim; Albert Shih; M John Hicks; Teresa S Wright; Moise L Levy; Kenneth L McClain; Carl E Allen
Journal:  J Pediatr       Date:  2014-10-21       Impact factor: 4.406

5.  How I treat Langerhans cell histiocytosis.

Authors:  Carl E Allen; Stephan Ladisch; Kenneth L McClain
Journal:  Blood       Date:  2015-03-31       Impact factor: 22.113

6.  Congenital self-healing reticulohistiocytosis.

Authors:  Young H Lee; Mala K Talekar; Catherine G Chung; Moshe D Bell; Andrea L Zaenglein
Journal:  J Clin Aesthet Dermatol       Date:  2014-02

7.  Progressive spinocerebellar degeneration "plus" associated with Langerhans cell histiocytosis: a new paraneoplastic syndrome?

Authors:  H Goldberg-Stern; R Weitz; R Zaizov; M Gornish; N Gadoth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

8.  Langerhans cell histiocytosis--clinical and epidemiological aspects.

Authors:  V Broadbent; R M Egeler; M E Nesbit
Journal:  Br J Cancer Suppl       Date:  1994-09

9.  Langerhan's cell histiocytosis: A single institutional experience.

Authors:  Tejinder Singh; C T Satheesh; L Appaji; B S Aruna Kumari; H S Mamatha; G V Giri; Clementina Rama Rao
Journal:  Indian J Med Paediatr Oncol       Date:  2010-04

10.  Coincidence FDG-PET in the evaluation of Langerhans' cell histiocytosis: preliminary findings.

Authors:  Larry A Binkovitz; Randal S Olshefski; Brent H Adler
Journal:  Pediatr Radiol       Date:  2003-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.